Menu
Menu
Genomic information is key for matching patients to the right clinical trials and treatments, but global genomic testing adoption has been slow and disparate.
Our unique approach to next-generation sequencing (NGS) assay deployment in laboratories across the world facilitates increased patient access to diagnostic testing for precision medicine, closing critical gaps in oncology care.
Test Implementation
Sponsored Testing
Medical Awareness
“Through this collaboration, we aim to enable the widespread application of precision medicine in oncology across Africa, and thus contributing to the improvement of patient outcomes across the African continent.
“Providing laboratories with innovative solutions to enable locally-delivered HRD testing is critically important, particularly in advanced ovarian cancer, where nearly half of diagnosed patients have HRD-positive tumors. We are pleased to work with SOPHiA GENETICS in their mission to empower laboratories with more options for HRD detection.”
SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise.
SOPHiA DDM™ Dx Hereditary Cancer Solution, SOPHiA DDM™ Dx RNAtarget Oncology Solution and SOPHiA DDM™ Dx Homologous Recombination Deficiency Solution are available as CE-IVD products for In Vitro Diagnostic Use in the European Economic Area (EEA), the United Kingdom and Switzerland. SOPHiA DDM™ Dx Myeloid Solution and SOPHiA DDM™ Dx Solid Tumor Solution are available as CE-IVD products for In Vitro Diagnostic Use in the EEA, the United Kingdom, Switzerland, and Israel. Information about products that may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact us to obtain the appropriate product information for your country of residence.
All third-party trademarks listed by SOPHiA GENETICS remain the property of their respective owners. Unless specifically identified as such, SOPHiA GENETICS’ use of third-party trademarks does not indicate any relationship, sponsorship, or endorsement between SOPHiA GENETICS and the owners of these trademarks. Any references by SOPHiA GENETICS to third-party trademarks is to identify the corresponding third-party goods and/or services and shall be considered nominative fair use under the trademark law.
Powered by Bioz
